Penstemon digitalis "finger": the flowers resemble fingers of a glove. The plant grows in moist, sandy soil in full sun in meadows, prairies, fields, wood margins, open woods and along railroad tracks. Its bloom period is from late spring to early summer. The plant is known to attract, butterflies, and birds such as hummingbirds. It tolerates deer browsing. Native states for "P. digitalis" include Iowa, Nebraska, and Missouri although it is less common in Iowan native prairies compared to other "Penstemon" species. The genus "Penstemon" is the largest in North America with 270 species. However, genome size was relatively unknown for the
New Drug Application Review should complete within 6 months. The decision comes in a "Complete Response Letter". Biologics, such as vaccines and many recombinant proteins used in medical treatments are generally approved by FDA via a Biologic License Application (BLA), rather than an NDA. The manufacture of biologics is considered to differ fundamentally from that of less complex chemicals, requiring a somewhat different approval process. Generic drugs that have already been approved via an NDA submitted by another maker are approved via an Abbreviated New Drug Application (ANDA), which does not require all of the clinical trials normally required for a new drug